#Icd 10 code for syncope trial

Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. 4. The United States Pharmacopeial Convention (USP). Tenth Revision, Clinical Modification (ICD-10-CM). International Classification of Diseases.

3. Centers for Disease Control and Prevention (CDC). Aliso Viejo, CA: Avanir Pharmaceuticals, Inc. 4 NUEDEXTA is not an antipsychotic medication, a psychotropic medication, nor a controlled substance. NUEDEXTA is a central nervous system (CNS) agent that is categorized in the 'Central Nervous System, Other' pharmacologic class in the United States Pharmacopeia and National Formulary (USP-NF). However, increases in dextromethorphan and/or quinidine levels are likely to be observed. NUEDEXTA has not been evaluated in patients with severe renal or hepatic impairment. No dose adjustments are required in patients with mild-to-moderate renal or hepatic impairment. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

The need for continued treatment should be reassessed periodically as spontaneous improvement of PBA symptoms occurs in some patients. 2įollowing this regimen, patients on NUEDEXTA had a mean 82% reduction in PBA episodes versus 45% on placebo at Week 12 in the STAR Pivotal trial.

#Icd 10 code for syncope trial

Efficacy beyond Week 1 in the STAR Pivotal trial was achieved with Q12H dosing. Titrate to 1 capsule every 12 hours on Day 8.